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doi:10.1Objectives: Cerebral ischemia can occur during cardiopulmonary bypass, especially during low flow. HBOC-
201 (OPK Biotech, Cambridge, Mass) is a hemoglobin-based oxygen-carrying solution that enhances oxygen
delivery. This project evaluated the benefits on total body and cerebral oxygen delivery and consumption using
HBOC-201 during cardiopulmonary bypass.
Methods: Twelve immature swinewere assigned to one of 2 groups. One group used HBOC-201 in pump prime,
and the other used donor porcine blood. Cardiopulmonary bypass was initiated and then flow was serially de-
creased from 100% to 75%, to 50%, and then back to full flow. At each interval, 15O positron emission tomo-
graphic analysis was performed, and blood was collected. Total body and cerebral oxygen delivery and
consumption were calculated. Statistical analysis was performed with a Tukey–Kramer adjusted P value based
on a repeated measures linear model on log-transformed data.
Results: Total and plasma hemoglobin levels were higher in the HBOC-201 group. Oxygen delivery and con-
sumption were not statistically different but did tend to be higher in the HBOC-201 group. Mixed venous sat-
uration was lower in the HBOC-201 group but not significant. Mild metabolic acidosis with increased lactate
levels developed in the blood group. Mean cerebral blood flow decreased in both groups when total flow was
50%. In the HBOC-201 group cerebral oxygen metabolism was maintained.
Conclusions: The addition of HBOC-201 for cardiopulmonary bypass appears to improve oxygen use and min-
imize anaerobic metabolism. Cerebral oxygen use was preserved in the HBOC-201 group, even during decrease
in blood flow. These findings support the reported improved oxygen-unloading properties of HBOC-201 and
might provide a benefit during cardiopulmonary bypass. (J Thorac Cardiovasc Surg 2011;142:411-7)HBOC-201 (OPK Biotech, Cambridge, Mass) is a bovine
hemoglobin-based oxygen carrier (HBOC). Developed as
red cell replacement, these fluids are being evaluated as ox-
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Sincreases the oxygen-carrying capacity of the plasma phase,
decreases the oxygen diffusion resistance, and facilitates
oxygen delivery to tissue beds.1,2 HBOC-201 is a high P50
(pressure of oxygen that causes the hemoglobin to be
50% saturated) HBOC: the P50 of HBOC-201 is 38 mm
Hg compared with 27 mm Hg for human intraerythrocytic
hemoglobin (Table 1). This decreased affinity enhances ox-
ygen offloading to tissues.3-5
Prior work6-9 with a porcine model of controlled
hemorrhagic shock demonstrated the potential benefits of
the enhanced tissue oxygenation. In acute and survival
models resuscitation with HBOC-201 led to anaerobic me-
tabolism reversal despite dramatically lower cardiac output,
mean arterial pressure, and mixed venous saturation with-
out significant end-organ injury. In these studies, despite
lower oxygen delivery and systemic hypotension, oxygen
use was maintained, and end-organ function was preserved.
15O positron emission tomography (PET) measures cere-
bral blood flow (CBF) and cerebral oxygen metabolism
(CMRO2) and has become the gold standard
10,11 for
cerebral perfusion studies. No studies with 15O PET
imaging during cardiopulmonary bypass (CPB) have beenrdiovascular Surgery c Volume 142, Number 2 411
Abbreviations and Acronyms
CaO2 ¼ arterial oxygen content
CBF ¼ cerebral blood flow
CK ¼ creatine kinase
CMRO2 ¼ cerebral oxygen metabolism
CPB ¼ cardiopulmonary bypass
DO2 ¼ oxygen delivery
HBOC ¼ hemoglobin-based oxygen carrier
P50 ¼ pressure of oxygen that causes the
hemoglobin to be 50% saturated
PET ¼ positron emission tomography
TNF-a ¼ tumor necrosis factor a
VO2 ¼ oxygen consumption
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Spublished, but 15O PET has been used to evaluate cerebral
metabolism in a porcine model after cardiac arrest.12 For
brain imaging, major advantages of PET with 15O (half-
life, 122.2 seconds) are that the images are rapidly acquired,
fully quantitative, and can be repeated every 10 minutes. A
limitation of using 15O is that an on-site cyclotron is re-
quired to generate the required oxygen radiotracers. Few
medical research facilities have the required equipment,
precluding widespread application.
Neurologic complications can occur after operations re-
quiring CPB. The common pathway is cerebral ischemia
leading to neuronal death. Because of the facilitated oxygen
delivery and reduced tissue ischemia during low flow, we hy-
pothesized that HBOC-201 during CPB might improve cere-
bral protection by minimizing overall end-organ ischemia.
No prior investigations have evaluated this hypothesis. How-
ever, other clinical situations with end-organ ischemia have
been evaluated. Inmyocardial infarctionmodels prophylactic
and therapeutic treatment with HBOC-201 led to significant
infarct size reduction.13,14 Porcine models of hemorrhagic
shock combined with traumatic brain injury15,16 with
HBOC-201 for resuscitation demonstrated rapidly restored
hemodynamics and improved brain tissue oxygenation.A ca-
nine model of isovolemic hemodilution found that tissue ox-
ygenation in both skeletal muscle and liver parenchyma was
increased to greater than baseline values17 in the HBOC-201
group. Therefore we measured CBF and CMRO2 values in
a porcine model of normothermic low-flow CPB.MATERIALS AND METHODS
Animal Model
This study was reviewed and approved by the Wilford Hall Medical
Center Animal Care and Use Committee. All animals were cared for ac-
cording to the ‘‘Guide for the care and use of laboratory animals.’’18 Twelve
Yorkshire swine (weight, 23.3  3.3 kg) were randomized to one of 2
groups. Animals were fasted but had access to water. Animals were pre-
medicated with intramuscular ketamine (15–20 mg/kg) and atropine
(0.04–0.4 mg/kg). Intravenous access was established. Mask induction412 The Journal of Thoracic and Cardiovascular Surgwith isoflurane (2.0%–4.0%) in 100% oxygen was performed, followed
by endotracheal intubation. Anesthesia was maintained with isoflurane
(0.25%–2.0%) in 100% oxygen, and the animals were mechanically
ventilated with a positive end-expiratory pressure of 3 cm H2O. Femoral
intravascular catheters were placed by means of a cutdown procedure.
Median sternotomy and systemic heparinization (300–500 U/kg adminis-
tered intravenously) were performed. The activated coagulation time was
maintained at greater than 450 seconds. A venous cannula was placed
through the right atrial appendage. An arterial cannula was placed in the
ascending aorta. The left atrium was vented through the appendage. The
aortic arch was mobilized, and the ligamentum arteriosum was ligated. A
fiberoptic positron (bþ) probewas placed in the right brachiocephalic artery
and advanced into the right common carotid artery.
The animals were transferred from the surgical suite to the PET scanner,
and the cannulae were connected to the bypass circuit. Positioning for PET
scanning was accomplished, baseline measurements were recorded, and
blood samples were collected. Before initiating CPB, additional anesthetic
with fentanyl (30–100 mg $ kg1 $ h1) and neuromuscular blockade with
pancuronium bromide (0.02–0.15 mg/kg administered intravenously)
were administered. Isoflurane (0.25%–2.0%) was continued through
a vaporizer on the CPB circuit.
Experimental Protocol
In group A HBOC-201 was added to the standard priming solution
(12.5 g of mannitol, 50 mEq of NaHCO3, and 10,000 units of heparin in
isotonic saline) to produce a systemic serum concentration of free hemo-
globin of 2 g/dL by using the following formula:
Vol HBOC ¼ desired ½ free Hg3 ðEBVþ circuit volumeÞ½Hg in HBOC ;
where EBV is defined as estimated blood volume (70 mL/kg), circuit vol-
ume is 800 mL, and hemoglobin (Hg) in HBOC is 13 g/dL.
In group B the same primewith a similar volume of donor porcinewhole
blood was used. Other than this difference in the priming solution, both
groups were treated identically. The bypass circuit consisted of an S-3
roller-head bypass system (Sorin Medical, Denver, Colo) with a Capiox
RX15 oxygenator, AF125X arterial filter, and HC05 hemoconcentrator
(Terumo Medical, Somerset, NJ) using 3/8-inch tubing for arterial and ve-
nous lines. Full-flow normothermic CPB (100 mL $ kg1 $ min1) was ini-
tiated and maintained for 30 minutes, and the flow was decreased to 75%
for 30 minutes and 50% for 30 minutes and then returned to full flow for 30
minutes. Animals were separated from CPB, observed for 30 minutes, and
then killed. Cardioplegic arrest was not performed. Vacuum-assisted ve-
nous drainage and venting of the left atrium were performed to optimize
venous drainage and ensure that no ventricular ejection contributed to car-
diac output. Hemodynamic support with dopamine infusion was used as
necessary. Heparinization was not reversed, and cannulaewere left in place
throughout all data acquisition. At each interval, 15O PET imaging was per-
formed, and arterial and venous blood samples were collected. Arterial
blood pressure was monitored continuously through the femoral arterial
line, and heart rate was monitored by means of continuous electrocardio-
graphic analysis. Core temperature was measured by using a rectal temper-
ature probe. CPB flow was measured with an ultrasonic flow probe on the
arterial inflow tubing and recorded at each interval.
15O tomographic analysis was performed on a research-dedicated Sie-
mens/CTI HRþscanner (Siemens/CTI, Knoxville, Tenn) in 2-dimensional
acquisitionmode to reduce scattered-photon counts. For calibration, a blank
scanwas performedbefore the animalswere placed on the scanner. For each
animal, a 10-minute transmission scan was done with a rotating rod source
of 68Ge to correct the subsequent emission scans. For CBF measurement,
1480 MBq of H2
15O in 6 mL of saline was injected as an intravenous bolus
beginning 20 seconds before scan initiation. CMRO2 was measured by us-
ing 4810MBq of 15O2 in a 2-L air bag delivered across the CPB oxygenator
membrane. Arterial input function was measured with a bþ probe systemery c August 2011
TABLE 1. Properties of HBOC-201
13 g/dL polymerized hemoglobin
<5% as unstabilized tetramers
Approximately 50% between 65 and 130 kd
<10% are>500 kd
Colloid oncotic pressure: 18 mm Hg
Half-life: 24–30 h
pH 7.8
KCl: 4 mmol/L
NaOH: 10 mmol/L
P50: 38 mm Hg
300 mOsm/kg
NaCl: 113 mmol/L
CaCl2: 1.4 mmol/L
Sodium lactate: 27 mmol/L
N-acetyl-L-cysteine: 200 mg/dL
<0.1 mg/mL free glutaraldehyde
<0.05 EU/mL endotoxin
P50, Pressure of oxygen that causes the hemoglobin to be 50% saturated.
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into the common carotid artery, and a second probe was placed outside the
body to remove background gamma radiation. PET images were recon-
structed with a standard, filtered back-projection algorithm with a 5-mm
FWHMHann filter. Decay and dead time corrections were done during im-
age reconstruction. The images were coregistered by anatomic magnetic
resonance images. Absolute whole-brain CBF (in milliliters per 100 g per
minute) and CMRO2 (in milliliters per 100 g per minute) were calculated
by using the Ohta method for different bypass stages. The cerebral oxygen
extraction fraction (OEF)was estimated from the relationship betweenCBF
and CMRO2 (ie, CMRO2 ¼ CBF 3 OEF 3 oxygen content).20
At each interval, arterial and mixed venous blood was collected and an-
alyzed with an on-site Radiometer ABL 510 (Copenhagen, Denmark) for
standard blood gas values, hemoglobin, co-oximetry, and lactate levels.
By using these data, the arterial and venous oxygen content was calculated.
Oxygen delivery, oxygen consumption, and the oxygen extraction ratio
were calculated at each bypass flow rate. At baseline and after separation
from CPB, blood was collected and stored for subsequent analysis. Com-
plete cell counting was performed on an ADVIA analyzer (Siemens
Healthcare, Deer Park, Ill) after completion of each experiment. Standard
serum chemistries were performed with a Vetscan analyzer (Abaxis, Union
City, Calif). Baseline and completion serum samples were analyzed on
a Radiometer ABL 510 for the concentration of cell-free hemoglobin.
Specimens for inflammatory mediators (tumor necrosis factor a [TNF-a]
and interleukin 6) were collected, stored at78C, and subsequently ana-
lyzed in batches by using ELISA kits (R&D Systems, Minneapolis,
Minn). Similarly, troponin (Life Diagnostics, West Chester, Pa) and crea-
tine kinase (CK) MB (Diagnostic Automation, Calabasas, Calif) levels
were determined by using ELISA kits on stored specimens in batches.
Data were summarized with the mean 1 standard deviation in original
units. Mean contrasts were carried out with a Tukey–Kramer adjusted P
value based on a repeated-measures linear model on log-transformed
data with a compound symmetric covariance assumption. All statistical
testing was 2-sided, with an experiment-wise significance level of 5%.
SAS Version 9.2 for Windows software (SAS Institute, Inc, Cary, NC)
was used throughout.RESULTS
All animals survived to completion of the protocol, with
the exception of 1 animal that was excluded because of loss
of airway with hemodynamic compromise. During transfer,The Journal of Thoracic and Cathis animal became extubated, leading to significant hyp-
oxia and hypercarbia with subsequent hemodynamic com-
promise. The data from this animal were discarded, and
the animal was not replaced. One animal had acute hind-
limb ischemia caused by arterial thrombosis at the femoral
artery catheter site. Hemodynamic and PET data were used
from this animal, but metabolic and inflammatory markers
that would have been influenced by the extremity ischemia
were not included in the data analysis. The mean weights of
the animals in both groups were not significantly different.
The mean volume of HBOC-201 used for each animal was
372  24 mL or 16.2  0.4 mL/kg.
Hemodynamics
In the HBOC group the mean arterial pressure was higher
and the mean heart rate remained lower (Figure 1). No an-
imals required the use of dopamine during CPB. Three
(60%) of 5 animals in the HBOC group compared with
zero (0%) of 6 in the no-HBOC group required transient
low-dose dopamine (3–5 mg $ kg1 $ min1) to maintain
a mean arterial pressure of 55 mm Hg or greater in the pe-
riod immediately after separation from bypass. At baseline,
animals were mildly hypothermic, but once bypass was
initiated, all animals returned to normothermia. There
were no significant differences in core temperatures be-
tween the 2 groups.
Global Oxygen Metabolism
The HBOC group had a significantly higher mean total
hemoglobin level at baseline (9.7  0.7 vs 8.5  0.7 g/dL,
P¼ .02), and this persisted throughout the protocol, includ-
ing after CPB (9.0  0.8 vs 7.6  0.7 g/dL, P ¼ .005).
Plasma hemoglobin was nearly undetectable at baseline
(0.1  0.1 g/dL in the HBOC group vs 0.02  0.04 g/dL
in the blood group). In the HBOC group the mean plasma
hemoglobin level increased to 2.2 0.3 g/dL (P¼ .05) com-
pared with 0.02  0.04 g/dL in the blood group after CPB.
Mean arterial oxygen content (CaO2) was also higher in
the HBOC group at baseline and all subsequent time points
(Table 2). The mean CaO2 value decreased from baseline in
both groups once CPB was initiated because of hemodilu-
tion with the priming solution. At each interval, CPB flow
changed as intended in the study design and did not vary
significantly between groups at each time point. Despite
the higher mean CaO2 value in the HBOC group, calculated
mean oxygen delivery (DO2) was not significantly different
between the 2 groups but did decrease relative to baseline as
mean CPB flow decreased. Calculated mean oxygen use
(VO2) did not vary significantly between groups. At 50%
CPB flow, the decrease in mean VO2 value became signifi-
cant relative to the baseline value. Mixed venous saturation
decreased significantly at the 75% flow rate in both groups
and remained decreased even after full flow had been
resumed.rdiovascular Surgery c Volume 142, Number 2 413
FIGURE 1. Heart rate and mean arterial pressure during cardiopulmonary bypass (CPB). *P  .001 between groups, @P<.001 compared with baseline,
and #P ¼ .02 compared with baseline.
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Mean methemoglobin percentages were similar at base-
line (0.7%  0.4% vs 1.3%  0.8%), remained at this
level in the blood group, and increased to a peak of 2.3%
 0.8% in the HBOC group versus 1.1%  0.5% in the
blood group (P<.001). At all time points after initiating by-
pass, the methemoglobin percentage was significantly
higher in the HBOC group. Mild metabolic acidosis devel-
oped in the blood group, as reflected by the mean arterial
base excess and mean arterial pH (Table 3). In the
HBOC-treated group these parameters were not statistically
different from baseline. In both groups mean serum lactate
levels were normal at baseline and increased as flow rate
was decreased, although to a lesser degree in the HBOC
group.15O PET
Mean CBF andmean cerebral metabolic rate of oxygen at
100% CPB flow was consistent with normal values for the
porcine brain. CBF was maintained at 75% CPB flow butTABLE 2. Oxygen delivery and consumption
HBOC-201 prime (n ¼ 5)
100% 75% 50% 10
Total hemoglobin (g/dL) 9.0  0.6y 8.7  0.7y 8.9  1.3y 8.4 
CPB flow (L/min) 2.3  0.2 1.7  0.1* 1.2  0.1* 2.3 
CaO2 (mL O2/dL) 12.8  0.6y 12.3  0.9* 12.9  1.6y 11.8 
SvO2 (%) 61.5  7.2 44.1  7.3* 36.8  6.4* 53.0 
DO2 (mL O2/min) 293  28 211  29* 150  29* 271 
VO2 (mL O2/min) 122  26 122  21 99  22* 134 
CPB, Cardiopulmonary bypass; CaO2, arterial oxygen content; SvO2, mixed venous oxyge
initial full flow (100%), within group. yP<.05 relative to initial full flow (100%), within
414 The Journal of Thoracic and Cardiovascular Surgdecreased significantly from the full-flow state in both
groups when total CPB flow was decreased to 50%, with
no significant difference between the 2 groups (Table 4).
Once full flow was resumed, the values for mean CBF ex-
ceeded baseline values. Mean CMRO2 was also maintained
at 75% of CPB flow in both groups. In the blood group the
mean CMRO2 value decreased significantly when total flow
was reduced to 50%. In the HBOC group the mean CMRO2
value also decreased, but the decrease did not reach signif-
icance (P¼ .14). Themean brain oxygen extraction fraction
increased as total flow, and the change became significant in
the HBOC group at 50% flow.Inflammatory Markers and Cardiac Enzymes
Serum levels of inflammatory markers, cardiac enzymes,
magnesium, and platelets are summarized in Table 5.
Values of all of these, with the exception of magnesium
and TNF-a, changed significantly from baseline to comple-
tion. Mean CK levels were increased at baseline because of
the sample being collected after opening of the chest andBlood prime (n ¼ 6)
0% 100% 75% 50% 100%
0.6* 7.4  0.4*,z 7.4  0.8*,z 7.4  0.8*,z 7.2  0.7*,z
0.2 2.4  0.5 1.8  0.3* 1.2  0.2* 2.4  0.4
0.7* 10.9  0.5*,z 10.9  1.3*,z 10.9  1.3*,z 10.4  1.2*,z
6.3y 65.4  8.2 51.2  9.7* 37.9  9.5* 57.6  10.1y
30y 257  57 190  34* 129  26* 246  58
27 105  38 95  18 86  28* 112  29
n saturation; DO2, oxygen delivery; VO2, oxygen consumption. *P  .001 relative to
group. zP<.05, between groups.
ery c August 2011
TABLE 3. Acid/base measurements
HBOC201 prime (n ¼ 4) Blood prime (n ¼ 6)
Baseline 100% 75% 50% 100% Off CPB Baseline 100% 75% 50% 100% Off CPB
BE (mEq/L) 6.0  4.1 6.4  3.1 7.0  4.1 3.9  3.4 5.5  2.7 4.1  3.9 5.6  3.4 7.6  3.3y 6.4  3.5 2.0  3.2y 2.6  4.1 4.2  4.3
pH 7.44  0.08 7.45  0.09 7.48  0.07 7.47  0.07 7.44  0.06 7.43  0.06 7.45  0.05 7.47  0.06 7.46  0.04 7.40  0.05 7.39  0.06y 7.41  0.06
PCO2 (mmHg) 46  5 45  9 42  3 38  4y 45  4 44  1 44  5 44  5 44  4 43  1 46  3 47  6
Lactate (mmol/L) 1.1  0.4 2.2  0.9* 2.5  0.6* 4.5  0.7* 3.4  1.5* 3.3  1.2* 1.5  .5 1.9  0.7 3.2  1.2* 6.5  1.7* 6.3 2.4*z 4.7  2.2*
PO2 (mmHg) 366  134 282  50 264  58 339  75 238  55 319  85 333  131 337  127 315  120 350  131 269  149 257  178y
CPB, Cardiopulmonary bypass; BE, arterial base excess; pH, arterial pH; Lactate, arterial lactate level. *P .001 relative to baseline, within group. yP .05 relative to baseline,
within group. zP ¼ .01, between groups.
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was performed during these procedures. Mean platelet
levels decreased after the CPB run, but no significant differ-
ence between groups was identified.
DISCUSSION
This is the first report of 15O PET scanning during CPB
to evaluate CBF and CMRO2. In addition, the effects of
HBOC-201 in the priming solution on hemodynamics, ox-
ygen delivery and consumption, cerebral perfusion and ox-
ygenation, and systemic inflammatory markers were
evaluated. During CPB, the mean arterial pressure was
slightly higher in the HBOC group, which is consistent
with the known mild vasoconstrictive properties of the
HBOC. This effect might be beneficial during CPB,
when the use of vasoconstrictors to maintain an adequate
perfusion pressure is often required. The need for low-
dose inotropic support for a brief period after separation
from CPB was unique to the HBOC group. The cause is
not clear, but the requirement was transient. The only prior
study evaluating HBOC-201 during CPB21 was performed
in a canine model, and the post-CPB left ventricular end-
diastolic pressure and dP/dt measurements were un-
changed from baseline, suggesting left ventricular function
was preserved. In our study the animals were not instru-
mented to determine these parameters. Visual inspection
of myocardial function was also impaired because of posi-
tioning within the PET scanner. Pigs are prone to develop-
ment of pulmonary hypertension in the perioperative
period after CPB. The potential contribution of pulmonary
vasoconstriction and hypertension cannot be evaluated in
our study. Future studies should further investigate the
cause underlying this transient need for inotropic/vasopres-
sor support.TABLE 4. Cerebral blood flow and oxygen use
HBOC-201 prime (n ¼ 5)
100% 75% 50%
CBF (mL/100 g/min) 51.4  8.3 44.8  8.4 33.8  10.7y 63
CMRO2 (mL/100 g/min) 2.97  0.72 2.85  0.51 2.49  0.36 3
OEF 0.46  0.14 0.53  0.11 0.61  0.17x 0.4
CBF, Cerebral blood flow; CMRO2, cerebral metabolic rate of oxygen; OEF, cerebral oxy
yP ¼ .02 relative to initial full flow (100%), within group. zP ¼ .01 relative to initial full fl
The Journal of Thoracic and CaThe mean hemoglobin concentration in the HBOC group
was higher at baseline and throughout the study. The unex-
pectedly low mean baseline hemoglobin level in the pigs
compared with the HBOC-201 formulation contributed to
this difference. HBOC-201 is a 13 g/dL solution (Table
5), and even though a similar volume of donor blood was
used for priming the circuit in the non-HBOC group, the
mean total hemoglobin level was consistently 1.5 g/dL
higher in the HBOC group. The mean CaO2 value is directly
related to the total hemoglobin value and therefore was also
higher in the HBOC group. The mean DO2 value was not
significantly different between the groups but did decrease
in a 1:1 relationship as the CPB flow was decreased. The
mean VO2 value seemed to be slightly higher in
the HBOC group, but this difference was not significant.
The mean VO2 value was maintained at near baseline values
at 75% flow by an increase in oxygen extraction in both
groups. The mean mixed venous oxygen saturation value
was also lower in the HBOC group but did not achieve sta-
tistical significance. Once CPB flow and the DO2 value were
decreased to 50%, the mean VO2 value decreased signifi-
cantly from baseline, and mean mixed venous saturation
was critically low in both groups. By maintaining the ani-
mals in a normothermic state and decreasing the flow rate,
VO2 became dependent on DO2.
Mean methemoglobin levels were higher in the HBOC
group, but with a peak level of 2.3%  0.8%, there is no
clinical significance. The enzyme methemoglobin reduc-
tase is located within erythrocytes and therefore unable to
act on hemoglobin outside the cell. In the blood group ani-
mals became mildly acidemic, with a higher peak lactate
level and a slower decrease after normal flow was restored.
Lactate is a product of cellular respiration during anaerobic
metabolism. This pattern of lactate in the HBOC groupBlood prime (n ¼ 6)
100% 100% 75% 50% 100%
.4  11.6 52.3  11.8 53.0  13.8 32.3  11.6* 68.3  11.5y
.1  0.52 2.92  0.96 3.17  0.71 2.08  0.65z 3.22  0.76
3  0.11 0.56  0.19 0.57  0.15 0.63  0.19 0.46  0.13
gen extraction fraction. *P ¼ .004 relative to initial full flow (100%), within group.
ow (100%), within group. xP ¼ .05 relative to initial full flow (100%), within group.
rdiovascular Surgery c Volume 142, Number 2 415
TABLE 5. Inflammatory markers and cardiac enzymes
HBOC201 prime Blood prime
Baseline Completion P value, within group Baseline Completion P value, within group P value, between groups
Total CK 928  528 3414  3104 .001 589  160 1653  602 <.001 NS
CK-MB 10  9 289  348 .02 5  7 125  290 .08 .05
Troponin I 0.1  0.1 9.8  3.8 <.001 0.1  0.1 4.6  1.6 <.001 .08
AST 47  9 252  182 <.001 41  12 144  70 <.001 NS
BUN 8  3 13  3 <.001 10  4 16  5 <.001 NS
Magnesium 2.0  0.5 2.2  0.5 NS 1.8  0.2 2.4  0.2 .003 NS
Platelets 313  132 198  52 .05 333  151 184  33 .004 NS
IL-6 101  78 587  765 .02 46  59 158  87 .09 .07
TNF-a 235  187 253  45 NS 138  54 166  78 NS NS
CK, Creatine kinase; CK-MB, creatine kinase MB; AST, aspartate aminotransferase; BUN, blood urea nitrogen; IL-6, interleukin 6; TNF-a, tumor necrosis factor a.
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ance. This finding supports our hypothesis that during the
low-flow state, improved oxygen unloading and tissue use
leads to less anaerobic metabolism.
Mean CBF was not significantly different between the 2
groups, and autoregulation prevented a significant decrease
in mean CBF until the CPB flow was decreased to 50%.
When flow was restored to 100 mL $ kg1 $ min1, an in-
crease in mean CBF was seen in both groups and has
been described as reactive hyperemia after an ischemic in-
sult. Similarly, at 75% flow, CMRO2 was no different than
full flow. When the flow was further reduced to 50%, only
the value in the blood group decreased significantly. The
mean CMRO2 value in the HBOC group decreased by
16%, whereas that in the blood group decreased 29% rela-
tive to full flow. Once flow was restored, the mean oxygen
metabolism returned to normal. These data further support
the hypothesis that using HBOC-201 as an oxygen thera-
peutic during CPB can maintain CMRO2 during low-flow
states by facilitating efficient oxygen use.
Levels of a number of the ischemia and inflammatory
markers increased significantly on average from baseline
to after CPB. This patternwas seen in total CK, CK-MB, tro-
ponin I, aspartate aminotransferase, and interleukin 6 levels.
In all of these, the mean increase was greater in the HBOC
group. The difference between values at completion was
only significantly higher in theHBOCgroup for CK-MB, al-
though the difference in troponin levels approached signifi-
cance (P ¼ .08). Interestingly, mean TNF-a levels did not
increase significantly during the experiment, and there
was no significant difference between groups. The cause
for these findings is unclear. Global mean oxygen delivery
was similar for both groups, and mean oxygen use was
slightly higher in the HBOC group. Histopathology was
not performed in this study. Previous studies found an in-
crease in liver function test results after HBOC treatment
without evidence of significant injury.7 The increased tropo-
nin level seen with HBOC has been previously reported in
a canine model using crystalloid cardioplegia.22 In that
study the magnitude of increase was much higher because416 The Journal of Thoracic and Cardiovascular Surgof the global myocardial ischemia induced by aortic cross-
clamp application but followed a similar pattern. However,
other models have found a myocardial protective effect of
HBOC. In a canine model of experimental myocardial is-
chemia14 using HBOC-201 as pretreatment, infarct size
was smaller and cardiac enzyme increase was significantly
less in the treatment group. In a rabbit model of coronary oc-
clusion,13 both prophylactic and therapeutic administration
of HBOC decreased the size of the myocardial infarction
without reducing the area of impaired perfusion. Increased
troponin levels after HBOC treatment continue to be a con-
cern, but the clinical effect of the mild increase in our study
requires further evaluation.
Our study has several limitations. First, the difference in
mean hemoglobin levels confounds the interpretation of the
oxygen delivery and consumption data. Although the mean
DO2 value was not significantly different between the
groups, the following question arises: Was the improved
performance in the HBOC group the result of the HBOC’s
properties or of the higher mean total hemoglobin level?
Although this is a weakness of our research study, it is ex-
actly how we expect this product would be used clinically.
When adding HBOC-201 to the bypass circuit, the circulat-
ing free hemoglobin would capitalize on the unique proper-
ties in the intraoperative and immediate postoperative
periods, when end-organ malperfusion is most likely. The
cell-free hemoglobin would be in addition to the red blood
cell hemoglobin and not a substitute for transfusion.
Second, using a healthy juvenile animal to evaluate end-
organ perfusion as a model for human patients with diffuse
atherosclerosis is imperfect. Situations in which the mech-
anism of decreased oxygen delivery is due to vascular oc-
clusive disease rather than low CPB flow rates might
behave differently than our model.
Finally, the nonsurvival model does not allow for correla-
tion of the immediate intraoperative findings to functional
neurologic outcomes. Future investigations should use a sur-
vival model to evaluate the postoperative neurologic status
and confirm that increased mean CMRO2 levels during CPB
lead to better clinical outcomes.ery c August 2011
McNeil et al Evolving Technology/Basic ScienceCONCLUSIONS
In our porcine model addition of HBOC-201 to the
pump-priming solution during CPB improves cerebral oxy-
genation and decreases overall tissue ischemia compared
with priming with donor whole blood. Further evaluation
of immediate post-CPB myocardial function and increased
cardiac enzyme levels after exposure to HBOC-201 should
be performed before clinical application. The unique
oxygen-unloading properties have the potential to improve
tissue oxygenation in numerous conditions of decreased
oxygen delivery.
HBOC-201 was provided free of charge by Biopure Corpora-
tion (Cambridge, Mass). Technical support was provided by the
59th Clinical Research Squadron, Wilford Hall Medical Center,
and the Laboratory Animal Resources and Research Imaging Cen-
ter at the University of Texas Health Science Center, San Antonio,
Texas. Assistance with statistical analysis was provided by Pra-
kash Nair, PhD, Department of Epidemiology and Biostatistics,
University of Texas Health Science Center, San Antonio, Texas.References
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